Helios Technologies (HLIO) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
18 May, 2026Executive summary
First quarter 2026 sales reached $228 million, up 17% year-over-year and 23% pro forma, exceeding guidance and driven by both Hydraulics and Electronics segments across all regions.
Delivered record cash generation and highest-ever quarterly sales for Enovation Controls, with strong execution of the CORE 2030 strategy targeting 5%+ annual organic sales growth and margin expansion.
Increased regular dividend by 33% (first increase in 29 years) and reduced net leverage to 1.6x net debt to adjusted EBITDA, the lowest since Q1 2018.
1Q26 results exceeded or met the top end of outlook, with a strong balance sheet and continued share repurchases.
Restructuring and production optimization continued, including leadership transitions and consolidation of operations.
Financial highlights
Net sales grew 17% year-over-year to $228.4 million; gross profit up 25% to $74.9 million, with gross margin expanding 220 bps to 32.8%.
Operating income increased 76% to $29.9 million; operating margin up 440 bps to 13.1%.
Adjusted EBITDA margin reached 20.4%, up 310 bps; diluted EPS was $0.59 (up 168%), and non-GAAP/adjusted EPS was $0.80 (up 82%).
Net income for Q1 2026 was $19.7 million, up 170% year-over-year.
Generated $24 million in operating cash and $17 million in free cash flow, both first quarter records.
Outlook and guidance
Raised full-year 2026 sales outlook to $840–$870 million, implying 8% pro forma growth at midpoint; adjusted EBITDA margin guided at 19.5%–21%.
Non-GAAP/adjusted EPS expected at $2.70–$3.00 (up to 17% growth); Q2 sales expected at $227–$232 million, with Q2 non-GAAP EPS of $0.78–$0.83.
Hydraulics sales expected at $520–$535 million (up 7–8%); Electronics at $320–$335 million (up 10–12%).
Capital expenditures for 2026 forecasted at 3.8–4.8% of sales.
Management expects challenging macroeconomic conditions to persist, with inflation, geopolitical risks, and tariff uncertainties impacting operations.
Latest events from Helios Technologies
- Strong 3Q25 growth and innovation drive a positive 2025 outlook, supported by a diversified portfolio.HLIO
Investor presentation13 Jul 2026 - Q1 2025 sales fell 8% YoY, but cash flow, margins, and debt reduction remained strong.HLIO
Q1 20258 Jul 2026 - Transformation, margin expansion, and operational resilience drive future growth.HLIO
Baird 2024 Global Industrials Conference8 Jul 2026 - Sequential margin and cash flow gains offset year-over-year sales declines.HLIO
Q2 20248 Jul 2026 - Imminent ARDS therapy launch in Japan and global phase III trial signal major growth ahead.HLIO
Jefferies Global Healthcare Conference 202611 Jun 2026 - Director elections, auditor ratification, and equity plan amendment up for shareholder vote.HLIO
Proxy filing7 May 2026 - Growth, governance, and sustainability drive key proposals and leadership changes for 2026.HLIO
Proxy filing4 May 2026 - Record Q4 and FY25 results, margin gains, and cash flow set up continued growth in FY26.HLIO
Q4 202527 Apr 2026 - Core 2030 targets $1.6B sales, 25%+ EBITDA margin, and accelerated innovation by 2030.HLIO
Investor Day 202620 Mar 2026